EWSR1 and neoplasm: Depletion of USP19 was shown to decrease EWSR1-FLI1 expression levels, but neither the expression of wild-type of EWSR1 nor FLI1, and to reduce tumor growth in vitro and in vivo indicating a potential therapeutic value for USP19 inhibition [101].